Improving access and appropriate use of medicines for mental disorders
This report, based on a consultative process and extensive literature reviews, provides information to improve access to essential medicines for mental disorders. It examines current barriers to access to psychotropic medicines and identifies key actions for overcoming those barriers, organized as a function of four access components – selection, availability, affordability, appropriate use. Further, it provides evidence-based guidance for appropriate use of medicines in people with mental disorders.
Sign Up to start bookmarking content
The Global Initiative for Chronic Obstructive Lung Disease (GOLD)
World Health Organization